The Alliance worked to convene over 80 organizations in a letter to the Drug Enforcement Administration (DEA) calling on the DEA to finalize the special registration for telemedicine. The anticipated registration would enable a practitioner to deliver, distribute, dispense, or prescribe via telemedicine a controlled substance to a patient who has not been medically examined in-person by the prescribing practitioner.

Special registration to prescribe controlled substances through telemedicine was originally called for in the Ryan Haight Act of 2008.

View the letter.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [125.83 KB]